Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Czock

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|March 22, 2023
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
Neuroimage. Clinical|May 16, 2025
Exploring the effect of multi-modal intervention against cognitive decline on atrophy and small vessel disease imaging markers in the AgeWell.de imaging studyFrauke Beyer, Lukas Kleine, Andrea Zülke, et al.
British Journal of Clinical Pharmacology|August 16, 2025
Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.deLaura K Lepenies, Hanna M Seidling, Alexander Pabst, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2026
Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging studyAndrea E Zülke, Frauke Beyer, Melanie Luppa, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 13, 2024
Quality of life in a high-risk group of elderly primary care patients: characteristics and potential for improvementJuliane Döhring, Martin Williamson, Christian Brettschneider, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Physical Activity Determinants in Older German Adults at Increased Dementia Risk with Multimorbidity: Baseline Results of the AgeWell.de StudyMaria Isabel Cardona, Marina Weißenborn, Isabel Zöllinger, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 23, 2018
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularisReto Rufener, Dominic Ritler, Jana Zielinski, et al.
Journal of Alzheimer'S Disease : JAD|April 12, 2024
Factors Associated with Lower Social Activity in German Older Adults at Increased Risk of Dementia: A Cross-Sectional AnalysisMaresa Buchholz, Isabel Zöllinger, Jochen René Thyrian, et al.
European Journal of Nutrition|December 31, 2024
Dietary changes following a lifestyle-based intervention for dementia risk reduction - results from the AgeWell.de studyAndrea E Zülke, Iris Blotenberg, Melanie Luppa, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|March 22, 2023
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
Neuroimage. Clinical|May 16, 2025
Exploring the effect of multi-modal intervention against cognitive decline on atrophy and small vessel disease imaging markers in the AgeWell.de imaging studyFrauke Beyer, Lukas Kleine, Andrea Zülke, et al.
British Journal of Clinical Pharmacology|August 16, 2025
Deprescribing drugs with anticholinergic effects in older patients with increased risk of dementia in the multicomponent intervention study AgeWell.deLaura K Lepenies, Hanna M Seidling, Alexander Pabst, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2026
Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging studyAndrea E Zülke, Frauke Beyer, Melanie Luppa, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 13, 2024
Quality of life in a high-risk group of elderly primary care patients: characteristics and potential for improvementJuliane Döhring, Martin Williamson, Christian Brettschneider, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Physical Activity Determinants in Older German Adults at Increased Dementia Risk with Multimorbidity: Baseline Results of the AgeWell.de StudyMaria Isabel Cardona, Marina Weißenborn, Isabel Zöllinger, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 23, 2018
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularisReto Rufener, Dominic Ritler, Jana Zielinski, et al.
Journal of Alzheimer'S Disease : JAD|April 12, 2024
Factors Associated with Lower Social Activity in German Older Adults at Increased Risk of Dementia: A Cross-Sectional AnalysisMaresa Buchholz, Isabel Zöllinger, Jochen René Thyrian, et al.
European Journal of Nutrition|December 31, 2024
Dietary changes following a lifestyle-based intervention for dementia risk reduction - results from the AgeWell.de studyAndrea E Zülke, Iris Blotenberg, Melanie Luppa, et al.
Pageof 11